{
  "meta": {
    "title": "24_Coagulation_Pathway_Disorders",
    "url": "https://brainandscalpel.vercel.app/24-coagulation-pathway-disorders-24833459.html",
    "scrapedAt": "2025-11-30T12:33:32.460Z"
  },
  "questions": [
    {
      "text": "What is the most common hereditary disease associated with life-threatening bleeding?",
      "choices": [
        {
          "id": 1,
          "text": "Hemophilia A"
        },
        {
          "id": 2,
          "text": "Immune thrombocytopenic purpura"
        },
        {
          "id": 3,
          "text": "Thrombotic thrombocytopenic purpura"
        },
        {
          "id": 4,
          "text": "von Willebrand disease"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The most common hereditary disease associated with life-threatening bleeding is <strong>hemophilia A</strong>.&nbsp;It&nbsp;is caused by <strong>mutations</strong> in <strong>factor VIII</strong>, an essential cofactor for factor IX in the coagulation cascade.</p>\n<p>Note: von Willebrand disease is the most common inherited bleeding disorder.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB5866",
      "difficulty": "medium"
    },
    {
      "text": "A 12-year-old boy presents with the following finding after a trivial fall. His lab investigations are given below. What is the most likely diagnosis?<div class='question-desc-html'><p>Platelet count - 4,00,000 /&mu;L</p>\n<p>Bleeding time - normal</p>\n<p>PT - normal</p>\n<p>aPTT - prolonged</p></div>",
      "choices": [
        {
          "id": 1,
          "text": "Immune thrombocytopenic purpura"
        },
        {
          "id": 2,
          "text": "Bernard Soulier syndrome"
        },
        {
          "id": 3,
          "text": "Hemophilia"
        },
        {
          "id": 4,
          "text": "Vitamin K deficiency"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The given clinical scenario showing <strong>hemarthrosis</strong> and <strong>elevated aPTT</strong> is suggestive of <strong>hemophilia</strong>.&nbsp;</p>\n<p>Specific tests for measuring levels of factor <strong>VIII</strong> and factor <strong>IX</strong> can determine whether it is hemophilia&nbsp;<strong>A</strong>&nbsp;or hemophilia&nbsp;<strong>B&nbsp;</strong>respectively.</p>\n<p><strong>Clinical features</strong> of hemophilia:</p>\n<ul>\n<li><strong>Hemarthroses</strong> - joint hemorrhages, later causing progressive deformities</li>\n<li>Recurrent bleeding</li>\n<li><strong>Pseudotumour</strong> syndrome -&nbsp;fascial hemorrhages that occur as blood-filled cysts with calcification and proliferation of fibroblasts, giving the appearance of the tumor</li>\n</ul>\n<p>It is associated with&nbsp;<strong>elevated aPTT</strong>&nbsp;and normal&nbsp;platelet count, bleeding time, and PT.</p>\n<p>Option A: In ITP, the platelet count is low and bleeding time is prolonged.</p>\n<p>Option B: In functional platelet disorders, like Bernard Soulier syndrome, the platelet count is normal and bleeding time is prolonged.</p>\n<p>Option D: In vitamin K deficiency, both PT and aPTT are prolonged. PT is relatively more prolonged than is the aPTT.</p><hr><h3>Related Pearl: Differences between Bleeding Disorders and Coagulation disorders</h3><table>\n<tbody>\n<tr>\n<td><strong>Finding</strong></td>\n<td><strong>Bleeding disorders</strong></td>\n<td><strong>Coagulation disorders</strong></td>\n</tr>\n<tr>\n<td>Cause</td>\n<td>\n<p>Quantitative/ Qualitative platelet abnormality</p>\n</td>\n<td>Deficiency of clotting factors</td>\n</tr>\n<tr>\n<td>Sex</td>\n<td>More common in females (commonly autoimmune)</td>\n<td>More common in males (commonly X-linked)</td>\n</tr>\n<tr>\n<td>Family history</td>\n<td>Rare (except in VWD)</td>\n<td>Common</td>\n</tr>\n<tr>\n<td>Petechiae</td>\n<td>Characteristic</td>\n<td>&nbsp;Rare</td>\n</tr>\n<tr>\n<td>Superficial ecchymosis</td>\n<td>Small and Multiple</td>\n<td>Large and Solitary</td>\n</tr>\n<tr>\n<td>Bleeding from superficial cuts&nbsp;</td>\n<td>Profuse</td>\n<td>Minimal persistent</td>\n</tr>\n<tr>\n<td>Hemarthrosis</td>\n<td>Rare</td>\n<td>Characteristic (most common-knee)</td>\n</tr>\n<tr>\n<td>Deep dissecting hematomas</td>\n<td>Rare</td>\n<td>Characteristic (most common-iliopsoas)</td>\n</tr>\n<tr>\n<td>Laboratory tests</td>\n<td>Bleeding time is prolonged</td>\n<td>PT and/or PTT are prolonged</td>\n</tr>\n<tr>\n<td>Most common</td>\n<td>Inherited: VWD</td>\n<td>\n<p>Inherited: Hemophilia A</p>\n<p>Acquired: Hemorrhagic diathesis of liver disease</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>VWD:&nbsp;von Willebrand disease</p>\n<p>PT: Prothrombin time</p>\n<p>PTT: Partial thromboplastin time</p>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/addfc07f1b1b4efda178c274d5ec2c05.PNG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB5869",
      "difficulty": "easy"
    },
    {
      "text": "A 7-year-old boy was found to have excessive bleeding following tooth extraction. Lab investigations revealed prolonged aPTT, decreased serum factor VIII levels and normal VwF activity. What is the mode of inheritance of this condition?",
      "choices": [
        {
          "id": 1,
          "text": "X-linked recessive"
        },
        {
          "id": 2,
          "text": "X-linked dominant"
        },
        {
          "id": 3,
          "text": "Autosomal dominant"
        },
        {
          "id": 4,
          "text": "Autosomal recessive"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The given clinical scenario is suggestive of<strong> Hemophilia A</strong> (factor VIII deficiency). It is inherited as an <strong>X-linked recessive</strong> trait. Hence, it affects mainly males and homozygous females.</p>\n<p><strong>Hemophilia B</strong> is also inherited as <strong>X-linked recessive</strong> trait.&nbsp;</p>\n<p><strong>Hemophilia</strong> <strong>C</strong> is inherited as an <strong>autosomal-recessive</strong> trait.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB5872",
      "difficulty": "easy"
    },
    {
      "text": "Which of the following statements is false about hemophilia?",
      "choices": [
        {
          "id": 1,
          "text": "Hemophilia B never affects females"
        },
        {
          "id": 2,
          "text": "Hemophilia C can affect females"
        },
        {
          "id": 3,
          "text": "Hemophilia A in female may indicate unfavourable lyonization"
        },
        {
          "id": 4,
          "text": "Hemophilia A can occur without any family history"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Hemophilia</strong>&nbsp;A and <strong>B</strong> mostly <strong>affect</strong> <strong>males</strong>, but&nbsp;rarely can affect <strong>females</strong> also.</p>\n<p>Hemophilia<strong>&nbsp;A</strong> is an X-linked recessive&nbsp;disorder, affecting&nbsp;mainly males and homozygous females.&nbsp;Rarely, excessive bleeding occurs in heterozygous females. It is due to the inactivation of the X chromosome bearing the normal <strong>factor VIII</strong> allele by chance in most cells <strong>(unfavourable&nbsp;lyonization)</strong>. About <strong>30%</strong> of patients have <strong>no family history</strong> and the disorder is caused due to new mutations.</p>\n<p>Hemophilia&nbsp;<strong>B</strong>&nbsp;is inherited as X-linked&nbsp;recessive trait. There is a <strong>deficiency</strong> of&nbsp;<strong>factor IX.</strong></p>\n<p>Hemophilia&nbsp;<strong>C</strong>&nbsp;is an autosomal-recessive condition and hence&nbsp;can occur in females.<strong>&nbsp;</strong>There is a&nbsp;<strong>deficiency</strong> of <strong>factor XI.</strong></p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC0500",
      "difficulty": "medium"
    },
    {
      "text": "A 10-year-old child with easy bruising was diagnosed to have moderate hemophilia A. What will be the percentage of normal factor VIII in her?",
      "choices": [
        {
          "id": 1,
          "text": "5-15%"
        },
        {
          "id": 2,
          "text": "2-5%"
        },
        {
          "id": 3,
          "text": "15-30%"
        },
        {
          "id": 4,
          "text": "40-60%"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>Patients with <strong>moderate hemophilia</strong> <strong>A</strong> have<strong> 2% - 5%</strong> of <strong>normal</strong> levels of <strong>factor VIII.</strong></p>\n<p>The clinical manifestations of Hemophilia A vary in severity, corresponding to the level of factor VIII present. They can be classified as: </p>\n<table>\n<tbody>\n<tr>\n<td><strong>Severity</strong></td>\n<td><strong>Levels of factor VIII</strong></td>\n</tr>\n<tr>\n<td>Mild</td>\n<td>6-50%</td>\n</tr>\n<tr>\n<td>Moderate</td>\n<td>2-5%</td>\n</tr>\n<tr>\n<td>Severe</td>\n<td>&lt;1%</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p> </p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB5874",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following lab findings are seen in patients with hemophilia A?<div class='question-desc-html'><table>\n<tbody>\n<tr>\n<td><strong>Options</strong></td>\n<td><strong>Platelet count</strong></td>\n<td><strong>Bleeding time</strong></td>\n<td><strong>PT</strong></td>\n<td><strong>aPTT</strong></td>\n</tr>\n<tr>\n<td>1</td>\n<td>Normal</td>\n<td>Normal</td>\n<td>Normal</td>\n<td>Increased</td>\n</tr>\n<tr>\n<td>2</td>\n<td>Decreased</td>\n<td>Increased&nbsp;</td>\n<td>Normal</td>\n<td>Normal</td>\n</tr>\n<tr>\n<td>3</td>\n<td>Normal&nbsp;</td>\n<td>Increased</td>\n<td>Normal</td>\n<td>Increased</td>\n</tr>\n<tr>\n<td>4</td>\n<td>Decreased</td>\n<td>Increased</td>\n<td>Increased</td>\n<td>Increased</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div></div>",
      "choices": [
        {
          "id": 1,
          "text": "Option 1"
        },
        {
          "id": 2,
          "text": "Option 2"
        },
        {
          "id": 3,
          "text": "Option 3"
        },
        {
          "id": 4,
          "text": "Option 4"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>Patients with <strong>hemophilia</strong> <strong>A</strong> have:</p>\n<ul>\n<li><strong>Prolonged</strong> partial thromboplastin time (<strong>aPTT</strong>) - intrinsic pathway abnormality</li>\n<li>Normal prothrombin time (PT)&nbsp;</li>\n<li>Normal bleeding time</li>\n<li>Normal platelet count</li>\n</ul><p>17th of April is observed as World Hemophilia Day.</p><hr><h3>Related Pearl: Summary of Laboratory findings in Hemostatic Disorders</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Disease</strong></p>\n</td>\n<td>\n<p><strong>Platelet count</strong></p>\n</td>\n<td>\n<p><strong>Bleeding time</strong></p>\n</td>\n<td>\n<p><strong>PT</strong></p>\n</td>\n<td>\n<p><strong>APTT</strong></p>\n</td>\n<td>\n<p><strong>Comments</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>ITP</p>\n</td>\n<td>\n<p>Decreased</p>\n</td>\n<td>\n<p>Increased</p>\n</td>\n<td>\n<p>Normal</p>\n</td>\n<td>\n<p>Nomal</p>\n</td>\n<td>\n<p>Auto-Antibodies against IIb-IIIa or Ib-IX</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Glanzmann thrombasthenia</p>\n</td>\n<td>\n<p>Normal</p>\n</td>\n<td>\n<p>Increased</p>\n</td>\n<td>\n<p>Normal</p>\n</td>\n<td>\n<p>Normal</p>\n</td>\n<td>\n<p>Defect in IIb/IIIa</p>\n<p>Autosomal recessive</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Bernard&ndash; Soulier syndrome</p>\n</td>\n<td>\n<p>Normal</p>\n</td>\n<td>\n<p>Increased</p>\n</td>\n<td>\n<p>Normal</p>\n</td>\n<td>\n<p>Normal</p>\n</td>\n<td>\n<p>Defect in Ib/IX</p>\n<p>Autosomal recessive</p>\n<p>Large platelets</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>von Willebrand disease</p>\n</td>\n<td>\n<p>Low or normal</p>\n</td>\n<td>\n<p>Increased</p>\n</td>\n<td>\n<p>Normal</p>\n</td>\n<td>\n<p>Increased</p>\n</td>\n<td>\n<p>3 subtypes</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Hemophilia A and B</p>\n</td>\n<td>\n<p>Normal</p>\n</td>\n<td>\n<p>Normal</p>\n</td>\n<td>\n<p>Normal</p>\n</td>\n<td>\n<p>Increased</p>\n</td>\n<td>\n<p>X-linked inheritance</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Liver disease</p>\n</td>\n<td>\n<p>Decreased</p>\n</td>\n<td>\n<p>Increased</p>\n</td>\n<td>\n<p>Increased</p>\n</td>\n<td>\n<p>Increased</p>\n</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>\n<p>Vitamin K deficiency</p>\n</td>\n<td>\n<p>Normal</p>\n</td>\n<td>\n<p>Normal</p>\n</td>\n<td>\n<p>Increased</p>\n</td>\n<td>\n<p>Increased</p>\n</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>\n<p>DIC</p>\n</td>\n<td>\n<p>Decreased</p>\n</td>\n<td>\n<p>Increased</p>\n</td>\n<td>\n<p>Increased</p>\n</td>\n<td>\n<p>Increased</p>\n</td>\n<td>\n<p>Increase in fibrin degradation products</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Aspirin</p>\n</td>\n<td>\n<p>Normal</p>\n</td>\n<td>\n<p>Increased</p>\n</td>\n<td>\n<p>Increased</p>\n</td>\n<td>\n<p>Normal</p>\n</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>\n<p>Warfarin</p>\n</td>\n<td>\n<p>Normal</p>\n</td>\n<td>\n<p>Normal</p>\n</td>\n<td>\n<p>&uarr; (Even in</p>\n<p>low dose)</p>\n</td>\n<td>\n<p>&uarr; (Even in</p>\n<p>low dose)</p>\n</td>\n<td>&nbsp;</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>ITP:&nbsp;Immune thrombocytopenic purpura</p>\n<p>DIC: Disseminated intravasculation coagulation</p><hr><h3>Related Pearl: Coagulation Pathways and its Abnormalities</h3><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/0fedd76b578148fc8ed55da37e66574cx1280x1995.JPEG\" alt=\"Pearl Image\"><table>\n<tbody>\n<tr>\n<td><strong>Test results</strong></td>\n<td><strong>Inherited causes</strong></td>\n<td><strong>Acquired causes</strong></td>\n</tr>\n<tr>\n<td>\n<p><strong>Prolonged PT </strong></p>\n<p>Evaluates extrinsic pathway factors</p>\n<p>Normal PT: 11-13 seconds</p>\n</td>\n<td>Factor VII deficiency </td>\n<td>\n<p>Mild vitamin K deficiency</p>\n<p>Liver disease</p>\n<p>Warfarin</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Prolonged aPTT </strong></p>\n<p>Evaluates intrinsic pathway factors</p>\n<p>Normal aPTT: 25-35 seconds</p>\n</td>\n<td>\n<p>Factors VIII, IX, XI deficiency</p>\n<p>Factor XII, prekallikrein, or HMW kininogen deficiency</p>\n<p>von Willebrand disease</p>\n</td>\n<td>Heparin, lupus anticoagulant, acquired von Willebrand disease</td>\n</tr>\n<tr>\n<td>\n<p>Prolonged PT + prolonged aPTT</p>\n<p>Evaluates common pathway factors</p>\n</td>\n<td>\n<p>Prothrombin (II), fibrinogen (I), factors V and factor X deficiencies</p>\n</td>\n<td>\n<p>Disseminated intravascular coagulation (DIC)</p>\n<p>Severe liver disease</p>\n<p>Severe vitamin K deficiency</p>\n<p>Direct thrombin inhibitor-argatroban, dabigatran</p>\n<p>Direct factor Xa inhibitor-rivaroxaban, apixaban, edoxaban</p>\n<p>Fondaparinux</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p> </p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB5876",
      "difficulty": "easy"
    },
    {
      "text": "A newborn baby develops severe umbilical cord bleeding soon after birth. Lab investigations are given below. What is the most likely diagnosis?<div class='question-desc-html'><p>Bleeding time - normal</p>\n<p>Platelet count - normal</p>\n<p>PT - normal</p>\n<p>aPTT - normal</p>\n<p>TT - normal</p>\n<p>Urea lysis test - positive</p></div>",
      "choices": [
        {
          "id": 1,
          "text": "Vitamin K deficiency"
        },
        {
          "id": 2,
          "text": "von Willebrand disease"
        },
        {
          "id": 3,
          "text": "Hemorrhagic disease of newborn"
        },
        {
          "id": 4,
          "text": "Factor XIII deficiency"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The given scenario is suggestive of&nbsp;<strong>factor XIII deficiency</strong>. A <strong>positive</strong> <strong>urea lysis</strong> test confirms the diagnosis.</p>\n<p><strong>Factor XIII</strong> is also known as <strong>clot-stabilizing </strong>factor that converts unstable fibrin clot into a&nbsp;stable clot. Its deficiency typically presents as excessive&nbsp;umbilical cord bleeding in the&nbsp;newborn.</p>\n<p><strong>Laboratory findings</strong> in this condition are:</p>\n<ul>\n<li>Normal levels of bleeding time (BT), platelet count, prothrombin time (PT), activated partial thromboplastin time (aPTT), and thrombin time (TT)</li>\n<li>Positive urea lysis test - confirmatory test which demonstrates&nbsp;lysis of clot by hyperosmolar urea in affected individuals</li>\n</ul>\n<p>The parameters for the given diseases:</p>\n<table>\n<tbody>\n<tr>\n<td>Condition</td>\n<td>PT</td>\n<td>aPTT</td>\n<td>BT</td>\n<td>TT</td>\n<td>Platelet count</td>\n<td>Urea lysis test&nbsp;</td>\n</tr>\n<tr>\n<td>Vitamin K deficiency</td>\n<td>increased</td>\n<td>increased</td>\n<td>increased</td>\n<td>normal/increased</td>\n<td>normal/decreased</td>\n<td>negative</td>\n</tr>\n<tr>\n<td>Von Willebrand disease</td>\n<td>normal</td>\n<td>normal/increased</td>\n<td>increased</td>\n<td>normal</td>\n<td>normal</td>\n<td>negative</td>\n</tr>\n<tr>\n<td>Hemorrhagic disease of newborn</td>\n<td>increased</td>\n<td>increased</td>\n<td>increased</td>\n<td>normal/increased</td>\n<td>normal/decreased</td>\n<td>negative</td>\n</tr>\n<tr>\n<td>Factor XIII deficiency</td>\n<td>normal</td>\n<td>normal</td>\n<td>normal</td>\n<td>normal</td>\n<td>normal</td>\n<td><strong>positive</strong></td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC0507",
      "difficulty": "medium"
    },
    {
      "text": "A Hemogram of a 23-year-old patient with a bleeding disorder is given below. Which of the following would you use to differentiate between heparin-induced thrombocytopenia and afibrinogenemia in this patient?<div class='question-desc-html'><p>Platelet count - 3,23,000 /&mu;L</p>\n<p>PT - elevated</p>\n<p>aPTT - elevated</p>\n<p>TT - elevated</p></div>",
      "choices": [
        {
          "id": 1,
          "text": "Reptilase"
        },
        {
          "id": 2,
          "text": "Ristocetin"
        },
        {
          "id": 3,
          "text": "Russel viper venom"
        },
        {
          "id": 4,
          "text": "Hyperosmolar urea"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Reptilase</strong> is a <strong>thrombin</strong> <strong>agonist</strong> which is used to <strong>differentiate</strong> heparin-induced thrombocytopenia (<strong>HIT</strong>) and <strong>afibrinogenemia</strong>.&nbsp;It is&nbsp;<strong>resistant </strong>to the&nbsp;action of<strong> heparin.</strong></p>\n<p>The differential diagnosis for normal platelet count with elevated PT, aPTT and TT are HIT and&nbsp;afibrinogenemia. After <strong>adding</strong>&nbsp;<strong>reptilase</strong>, if the <strong>TT</strong> is <strong>corrected</strong>, it points to <strong>HIT</strong>. In&nbsp;<strong>afibrinogenemia,</strong>&nbsp;since there is an&nbsp;<strong>absence</strong> of <strong>fibrin</strong>, there is <strong>no change</strong> in the TT.&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC0508",
      "difficulty": "hard"
    },
    {
      "text": "A 1-year-old child was diagnosed to have Kasabach-Merritt syndrome. What is this condition associated with?",
      "choices": [
        {
          "id": 1,
          "text": "Thrombotic thrombocytopenic purpura"
        },
        {
          "id": 2,
          "text": "Disseminated intravascular coagulation"
        },
        {
          "id": 3,
          "text": "Immune thrombocytopenic purpura"
        },
        {
          "id": 4,
          "text": "Hemolytic uremic syndrome"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Kasabach&ndash;Merritt syndrome</strong> is associated with <strong>DIC</strong> (disseminated intravascular coagulation).&nbsp;This syndrome is characterised by the following features:</p>\n<ul>\n<li>Rapidly growing vascular tumour</li>\n<li>Thrombocytopenia</li>\n<li>Microangiopathic haemolytic anaemia</li>\n<li>Consumptive coagulopathy</li>\n</ul>\n<p>An unusual form of DIC occurs in association with giant hemangiomas. In this type, <strong>stasis</strong> and recurrent <strong>trauma</strong> to the fragile <strong>blood vessels</strong> cause <strong>thrombi</strong> to <strong>form</strong> within the neoplasm.</p>\n<p>The image given below shows a reddish-blue lesion covering the lower part of the abdomen. It is&nbsp;a&nbsp;caverno-capillary haemangioma seen in&nbsp;Kasabach&ndash;Merritt syndrome.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/02cca95d7a514aeaa95e2e5c8161135ex982x550.JPEG\" alt=\"Explanation Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB5877",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following clotting factor deficiency will not affect clotting in vivo?",
      "choices": [
        {
          "id": 1,
          "text": "Factor VII"
        },
        {
          "id": 2,
          "text": "Factor V"
        },
        {
          "id": 3,
          "text": "Factor XII"
        },
        {
          "id": 4,
          "text": "Factor  IX"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>Factor XII&nbsp;deficiency will not affect the clotting in vivo.</p>\n<p>Unlike the clotting cascade in the lab (<strong>in vitro</strong>), the cascade in the body (<strong>in</strong> <strong>vivo</strong>) differs slightly - as <strong>tissue factor</strong> (TF) is the major <strong>initiator</strong> of the cascade. The <strong>TF/VIIa complex</strong> is the most important activator of <strong>factor IX</strong> and <strong>factor IXa/factor VIIIa complex</strong> is the most important activator of <strong>factor X</strong>. Factor V is involved in both the pathways as shown in the image below.</p>\n<p>The coagulation cascade in the <strong>laboratory</strong>:</p>\n<ul>\n<li><strong>Extrinsic </strong>pathway sequence (in a test tube):&nbsp; Tissue factor &rarr; Factor VII &rarr; Factor X.</li>\n<li><strong>Intrinsic </strong>pathway sequence (in a test tube):&nbsp;Factor XII &rarr;&nbsp; Factor XI&nbsp;&rarr; Factor IX&nbsp;&rarr; Factor&nbsp;X&nbsp;</li>\n</ul>\n<p>Laboratory&nbsp;methods to<strong> initiate </strong>clotting include:</p>\n<ul>\n<li>Intrinsic pathway - adding phospholipids, calcium, and either a negatively charged substance such as glass beads</li>\n<li>Extrinsic pathway - a source of tissue factor&nbsp;</li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/57039f8bba4a42d9aad91000bdc34855x600x578.JPEG\" alt=\"Explanation Image\"><hr><h3>Related Pearl: Coagulation Pathways and its Abnormalities</h3><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/0fedd76b578148fc8ed55da37e66574cx1280x1995.JPEG\" alt=\"Pearl Image\"><table>\n<tbody>\n<tr>\n<td><strong>Test results</strong></td>\n<td><strong>Inherited causes</strong></td>\n<td><strong>Acquired causes</strong></td>\n</tr>\n<tr>\n<td>\n<p><strong>Prolonged PT </strong></p>\n<p>Evaluates extrinsic pathway factors</p>\n<p>Normal PT: 11-13 seconds</p>\n</td>\n<td>Factor VII deficiency </td>\n<td>\n<p>Mild vitamin K deficiency</p>\n<p>Liver disease</p>\n<p>Warfarin</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Prolonged aPTT </strong></p>\n<p>Evaluates intrinsic pathway factors</p>\n<p>Normal aPTT: 25-35 seconds</p>\n</td>\n<td>\n<p>Factors VIII, IX, XI deficiency</p>\n<p>Factor XII, prekallikrein, or HMW kininogen deficiency</p>\n<p>von Willebrand disease</p>\n</td>\n<td>Heparin, lupus anticoagulant, acquired von Willebrand disease</td>\n</tr>\n<tr>\n<td>\n<p>Prolonged PT + prolonged aPTT</p>\n<p>Evaluates common pathway factors</p>\n</td>\n<td>\n<p>Prothrombin (II), fibrinogen (I), factors V and factor X deficiencies</p>\n</td>\n<td>\n<p>Disseminated intravascular coagulation (DIC)</p>\n<p>Severe liver disease</p>\n<p>Severe vitamin K deficiency</p>\n<p>Direct thrombin inhibitor-argatroban, dabigatran</p>\n<p>Direct factor Xa inhibitor-rivaroxaban, apixaban, edoxaban</p>\n<p>Fondaparinux</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p> </p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD6779",
      "difficulty": "hard"
    },
    {
      "text": "Which test evaluates the extrinsic pathway?",
      "choices": [
        {
          "id": 1,
          "text": "APTT"
        },
        {
          "id": 2,
          "text": "PT"
        },
        {
          "id": 3,
          "text": "TT"
        },
        {
          "id": 4,
          "text": "Bleeding time"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Prothrombin time</strong>&nbsp;(PT) evaluates the <strong>extrinsic pathway </strong>of coagulation.</p>\n<p>PT&nbsp;<strong>measures</strong> the <strong>clotting time</strong> of plasma in the presence of an optimal concentration of tissue extract (<strong>thromboplastin</strong>). This indicates the overall efficiency of the extrinsic clotting system.</p>\n<p><strong>Causes</strong> of<strong> prolonged PT:</strong></p>\n<ul>\n<li>Administration of oral anticoagulant drugs - vitamin K antagonists</li>\n<li>Liver disease - obstructive jaundice</li>\n<li>Vitamin K deficiency</li>\n<li>Disseminated intravascular coagulation</li>\n<li>Previously undiagnosed factor VII, X, V or prothrombin deficiency or defect (rare)</li>\n</ul>\n<p>Activated partial thromboplastin time (<strong>APTT</strong>)&nbsp;measures the <strong>clotting time</strong> of plasma after the activation of contact factors and the addition of phospholipid and CaCl<sub>2</sub>, but <strong>without</strong> added tissue <strong>thromboplastin</strong>. It indicates the overall efficiency of the <strong>intrinsic</strong> <strong>pathway</strong>.</p>\n<p><strong>Causes </strong>of<strong> prolonged APTT:</strong></p>\n<ul>\n<li>Disseminated intravascular coagulation</li>\n<li>Liver disease</li>\n<li>Massive transfusion with plasma-depleted red blood cells</li>\n<li>Administration of or contamination with heparin or other anticoagulants</li>\n<li>A circulating anticoagulant (inhibitor)</li>\n<li>Deficiency of a coagulation factor other than factor VII</li>\n<li>Intake of oral anticoagulant drugs</li>\n<li>Vitamin K deficiency</li>\n</ul><hr><h3>Related Pearl: Coagulation Pathways and its Abnormalities</h3><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/0fedd76b578148fc8ed55da37e66574cx1280x1995.JPEG\" alt=\"Pearl Image\"><table>\n<tbody>\n<tr>\n<td><strong>Test results</strong></td>\n<td><strong>Inherited causes</strong></td>\n<td><strong>Acquired causes</strong></td>\n</tr>\n<tr>\n<td>\n<p><strong>Prolonged PT </strong></p>\n<p>Evaluates extrinsic pathway factors</p>\n<p>Normal PT: 11-13 seconds</p>\n</td>\n<td>Factor VII deficiency </td>\n<td>\n<p>Mild vitamin K deficiency</p>\n<p>Liver disease</p>\n<p>Warfarin</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Prolonged aPTT </strong></p>\n<p>Evaluates intrinsic pathway factors</p>\n<p>Normal aPTT: 25-35 seconds</p>\n</td>\n<td>\n<p>Factors VIII, IX, XI deficiency</p>\n<p>Factor XII, prekallikrein, or HMW kininogen deficiency</p>\n<p>von Willebrand disease</p>\n</td>\n<td>Heparin, lupus anticoagulant, acquired von Willebrand disease</td>\n</tr>\n<tr>\n<td>\n<p>Prolonged PT + prolonged aPTT</p>\n<p>Evaluates common pathway factors</p>\n</td>\n<td>\n<p>Prothrombin (II), fibrinogen (I), factors V and factor X deficiencies</p>\n</td>\n<td>\n<p>Disseminated intravascular coagulation (DIC)</p>\n<p>Severe liver disease</p>\n<p>Severe vitamin K deficiency</p>\n<p>Direct thrombin inhibitor-argatroban, dabigatran</p>\n<p>Direct factor Xa inhibitor-rivaroxaban, apixaban, edoxaban</p>\n<p>Fondaparinux</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p> </p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB5861",
      "difficulty": "easy"
    },
    {
      "text": "You are collecting a blood sample to send for prothrombin time in a patient in the ward. Which of the following is true about this investigation?",
      "choices": [
        {
          "id": 1,
          "text": "Sample must be immediately refrigerated"
        },
        {
          "id": 2,
          "text": "Sample must contain platelet-rich plasma"
        },
        {
          "id": 3,
          "text": "Test must be done within 2 hours of sample collection"
        },
        {
          "id": 4,
          "text": "Sample is activated with kaolin"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The test for <strong>prothrombin time</strong> is done <strong>within</strong> <strong>2 hours</strong>.</p>\n<p>The differences between PT and aPTT are:</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Feature</strong></td>\n<td><strong>PT</strong></td>\n<td><strong>aPTT</strong></td>\n</tr>\n<tr>\n<td>Coagulation pathway tested</td>\n<td>Extrinsic and common</td>\n<td>Intrinsic and common</td>\n</tr>\n<tr>\n<td>Normal value</td>\n<td>11-13 seconds</td>\n<td>25-35 seconds</td>\n</tr>\n<tr>\n<td>Sample</td>\n<td>Platelet-poor plasma</td>\n<td>Platelet-poor plasma</td>\n</tr>\n<tr>\n<td>Activating agent</td>\n<td>Thomboplastin</td>\n<td>\n<p>Kaolin</p>\n<p>Silica</p>\n<p>Ellagic acid</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p> </p><hr><h3>Related Pearl: Parameters of the coagulation pathway and its uses</h3><p><strong> Parameters of the coagulation pathway and its uses</strong></p>\n<table>\n<tbody>\n<tr>\n<td><strong>Parameter </strong></td>\n<td><strong>Uses</strong></td>\n</tr>\n<tr>\n<td>Prothrombin Time (PT)</td>\n<td>It is used to monitor the functioning of the extrinsic and the common coagulation pathways. Normal PT is 11–13 seconds.</td>\n</tr>\n<tr>\n<td>Activated partial thromboplastin time (aPTT)</td>\n<td>It is used to monitor the functioning of the intrinsic and the common coagulation pathways. Normal aPTT is 25–35 seconds. A relatively rare cause of prolonged aPTT is the presence of antibodies against coagulation plasma proteins called inhibitors. It can be seen due to the following reasons: Hemophilia A and B patients receiving clotting factors to control their bleeding episodes, Pregnancy, Autoimmune diseases, Malignancies (lymphoma, prostate cancer), and Dermatologic conditions.</td>\n</tr>\n<tr>\n<td>Thrombin time (TT)</td>\n<td>It is used for testing the conversion of fibrinogen into fibrin and depends on adequate fibrinogen levels. </td>\n</tr>\n<tr>\n<td>Bleeding time (BT)</td>\n<td>It is the time taken for a standardized skin puncture to stop bleeding. It tests the ability of blood vessels to constrict and platelets to form a hemostatic plug. </td>\n</tr>\n<tr>\n<td>Fibrin degradation products (FDPs)</td>\n<td>They are used to assess the fibrinolytic activity, and they are increased in disseminated intravascular coagulation (DIC). </td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><hr><h3>Related Pearl: Coagulation Pathways and its Abnormalities</h3><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/0fedd76b578148fc8ed55da37e66574cx1280x1995.JPEG\" alt=\"Pearl Image\"><table>\n<tbody>\n<tr>\n<td><strong>Test results</strong></td>\n<td><strong>Inherited causes</strong></td>\n<td><strong>Acquired causes</strong></td>\n</tr>\n<tr>\n<td>\n<p><strong>Prolonged PT </strong></p>\n<p>Evaluates extrinsic pathway factors</p>\n<p>Normal PT: 11-13 seconds</p>\n</td>\n<td>Factor VII deficiency </td>\n<td>\n<p>Mild vitamin K deficiency</p>\n<p>Liver disease</p>\n<p>Warfarin</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Prolonged aPTT </strong></p>\n<p>Evaluates intrinsic pathway factors</p>\n<p>Normal aPTT: 25-35 seconds</p>\n</td>\n<td>\n<p>Factors VIII, IX, XI deficiency</p>\n<p>Factor XII, prekallikrein, or HMW kininogen deficiency</p>\n<p>von Willebrand disease</p>\n</td>\n<td>Heparin, lupus anticoagulant, acquired von Willebrand disease</td>\n</tr>\n<tr>\n<td>\n<p>Prolonged PT + prolonged aPTT</p>\n<p>Evaluates common pathway factors</p>\n</td>\n<td>\n<p>Prothrombin (II), fibrinogen (I), factors V and factor X deficiencies</p>\n</td>\n<td>\n<p>Disseminated intravascular coagulation (DIC)</p>\n<p>Severe liver disease</p>\n<p>Severe vitamin K deficiency</p>\n<p>Direct thrombin inhibitor-argatroban, dabigatran</p>\n<p>Direct factor Xa inhibitor-rivaroxaban, apixaban, edoxaban</p>\n<p>Fondaparinux</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p> </p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB5864",
      "difficulty": "medium"
    },
    {
      "text": "At what temperature should you store the sample for antiphospholipid antibody factor assays?",
      "choices": [
        {
          "id": 1,
          "text": "Room temperature"
        },
        {
          "id": 2,
          "text": "4 to 8 degrees"
        },
        {
          "id": 3,
          "text": "<4 degree"
        },
        {
          "id": 4,
          "text": "-8 degree"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><span class=\"TextRun SCXW158764989\" lang=\"EN-GB\" xml:lang=\"EN-GB\"><span class=\"NormalTextRun SCXW158764989\">The sample for <strong>antiphospholipid&nbsp;antibody assay</strong> must be stored at <strong>&lt;4&deg;.</strong></span></span></p>\n<p><span class=\"TextRun SCXW158764989\" lang=\"EN-GB\" xml:lang=\"EN-GB\"><span class=\"NormalTextRun SCXW158764989\">Samples for <strong>coagulation studies</strong> should be stored&nbsp;</span></span><span class=\"TextRun SCXW158764989\" lang=\"EN-GB\" xml:lang=\"EN-GB\"><span class=\"NormalTextRun SCXW158764989\">always at <strong>room temperature</strong> (20 to 25 degrees).</span></span></p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC0509",
      "difficulty": "hard"
    },
    {
      "text": "A 50-year-old male patient presents to the casualty with severe bleeding following a road traffic accident. He is a known cardiac disease patient on anticoagulant therapy.  As an intern, you were asked to collect blood for coagulation studies. Which colour vacutainer will you pick?",
      "choices": [
        {
          "id": 1,
          "text": "Lavender"
        },
        {
          "id": 2,
          "text": "Green"
        },
        {
          "id": 3,
          "text": "Red"
        },
        {
          "id": 4,
          "text": "Blue"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The most commonly used <strong>vacutainer</strong> for <strong>coagulation studies</strong> is<strong>&nbsp;</strong>a<strong> blue </strong>vacutainer<strong>&nbsp;</strong>containing <strong>t</strong><strong>risodium citrate</strong>.</p>\n<p>The benefits of&nbsp;trisodium&nbsp;citrate are that the <strong>calcium</strong> ion is <strong>neutralized</strong> more <strong>rapidly</strong> in citrate.</p>\n<p>Other anticoagulants are unacceptable for coagulation studies. The labile factors (factors V and&nbsp;VIII) are unstable in oxalate (grey), whereas heparin (green) and EDTA (lavender) directly inhibit the coagulation process and interfere with end-point determinations. Also, activated partial thromboplastin time (aPTT) tests are more sensitive to the presence of heparin (green).</p>\n<p>The image given below shows colour coding of vacutainers with the anticoagulant used and their practical uses.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/da483a0ca63e4a4d940f3175927ac688x1280x2189.JPEG\" alt=\"Explanation Image\"><p>Note:&nbsp;Heparin&nbsp;is used for blood sample collection for electrolyte estimation.</p><hr><h3>Related Pearl: Anticoagulants in Vacutainers and their Uses</h3><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/208956b39e504182a7fab1330d186f3cx1280x2189.JPEG\" alt=\"Pearl Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC0506",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following is the color of vacutainer containing sodium fluoride as a content?",
      "choices": [
        {
          "id": 1,
          "text": "Red"
        },
        {
          "id": 2,
          "text": "Grey"
        },
        {
          "id": 3,
          "text": "Blue"
        },
        {
          "id": 4,
          "text": "Yellow"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Sodium fluoride</strong> is present in the <strong>grey </strong>coloured tube.</p>\n<p>Sodium fluoride&nbsp;<strong>inhibits glycolysis.&nbsp;</strong>Hence, is used for the <strong>estimation</strong> of <strong>blood glucose </strong>and<strong> alcohol.</strong></p><hr><h3>Related Pearl: Anticoagulants in Vacutainers and their Uses</h3><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/208956b39e504182a7fab1330d186f3cx1280x2189.JPEG\" alt=\"Pearl Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC7084",
      "difficulty": "easy"
    },
    {
      "text": "A child was brought to the emergency department with a big lesion on his forearm. As a surgery resident you decide to excise the lesion in the emergency operation theatre. Which of the following investigations will test the entire coagulation pathway?",
      "choices": [
        {
          "id": 1,
          "text": "Activated partial thromboplastin time"
        },
        {
          "id": 2,
          "text": "Prothrombin time"
        },
        {
          "id": 3,
          "text": "Thromboelastography"
        },
        {
          "id": 4,
          "text": "Bleeding time"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Thromboelastography</strong> (TEG)&nbsp;tests the <strong>entire coagulation pathway</strong>. It measures coagulation cascade, platelet function, and fibrinolysis.</p>\n<p>It&nbsp;is a<strong>&nbsp;</strong>test that <strong>quantitatively</strong> measures the ability of whole blood to form a clot. The advantages are:</p>\n<ul>\n<li class=\"half_rhythm\">\n<div>Global assessment of blood coagulability, including coagulation cascade, platelet function, and fibrinolysis</div>\n</li>\n<li class=\"half_rhythm\">\n<div>Rapid real-time bedside test with a simple methodology (point-of-care testing)</div>\n</li>\n<li class=\"half_rhythm\">\n<div>Diagnosis of coagulopathic bleeding</div>\n</li>\n<li class=\"half_rhythm\">\n<div>Guide transfusion therapy and decrease the use of blood products</div>\n</li>\n<li class=\"half_rhythm\">\n<div>Detect dynamic changes in blood coagulation during resuscitation</div>\n</li>\n<li class=\"half_rhythm\">\n<div>Predict the clinical efficacy of therapeutic agents affecting blood coagulability</div>\n</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD6752",
      "difficulty": "easy"
    }
  ]
}